Ali Ardakani
Vorstandsvorsitzender bei Lexi Pharma, Inc.
Profil
Ali Ardakani is the founder of Niiki Pharma, Inc. which was founded in 2007.
He held the title of Vice President-Operations & Development from 2007 to 2013.
Currently, he is the Chief Executive Officer at Lexi Pharma, Inc., a Director at Altum Pharmaceuticals, Inc., and the Vice President-Device & Business Development at Beyond Air Ltd.
In the past, he worked as a Director-Corporate Development at iCell Therapeutics, Inc. from 2005 to 2006, as a Principal at PulmoNOx Medical, Inc. from 2001 to 2005, and as a Vice President-Operations at EquATec, Inc. from 2002 to 2005.
He also held the title of Senior VP-Device & Business Development at Beyond Air, Inc.
Aktive Positionen von Ali Ardakani
| Unternehmen | Position | Beginn |
|---|---|---|
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Corporate Officer/Principal | - |
Altum Pharmaceuticals, Inc.
 Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | - |
Lexi Pharma, Inc.
 Lexi Pharma, Inc. Pharmaceuticals: GenericHealth Technology Lexi Pharma, Inc. engages in business of developing genetic drugs for anti-tumor activities. It focuses on the development of AP-002 a new chemical entity small and novel molecule, that selectively targets bone resorption while also demonstrating anti-tumor activities. The company is headquartered in Canada. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Ali Ardakani
| Unternehmen | Position | Ende |
|---|---|---|
| BEYOND AIR, INC. | Corporate Officer/Principal | 01.12.2019 |
Niiki Pharma, Inc.
 Niiki Pharma, Inc. Pharmaceuticals: OtherHealth Technology Niiki Pharma, Inc. manufactures chemicals and botanical products. It specializes in cancer treatments directed at novel cellular targets and related companion diagnostics. The company was founded by Hooshmand Sheshbaradaran, Ardakana Ali and Jay Z. Zhang in 2007 and is headquartered in Hoboken, NJ. | Gründer | 01.07.2013 |
| iCell Therapeutics, Inc. | Corporate Officer/Principal | 01.12.2006 |
PulmoNOx Medical, Inc.
 PulmoNOx Medical, Inc. Miscellaneous Commercial ServicesCommercial Services PulmoNOx Medical, Inc. specializes in research, development and commercialization of nitric oxide technologies and products. The company was founded by John W. Randy Miller in 1990 and is headquartered in Tofield, Canada. | Corporate Officer/Principal | 01.03.2005 |
| EquATec, Inc. | Geschäftsführer | 01.03.2005 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BEYOND AIR, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Niiki Pharma, Inc.
Niiki Pharma, Inc. Pharmaceuticals: OtherHealth Technology Niiki Pharma, Inc. manufactures chemicals and botanical products. It specializes in cancer treatments directed at novel cellular targets and related companion diagnostics. The company was founded by Hooshmand Sheshbaradaran, Ardakana Ali and Jay Z. Zhang in 2007 and is headquartered in Hoboken, NJ. | Health Technology |
PulmoNOx Medical, Inc.
PulmoNOx Medical, Inc. Miscellaneous Commercial ServicesCommercial Services PulmoNOx Medical, Inc. specializes in research, development and commercialization of nitric oxide technologies and products. The company was founded by John W. Randy Miller in 1990 and is headquartered in Tofield, Canada. | Commercial Services |
| iCell Therapeutics, Inc. | |
| EquATec, Inc. | |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Health Technology |
Lexi Pharma, Inc.
Lexi Pharma, Inc. Pharmaceuticals: GenericHealth Technology Lexi Pharma, Inc. engages in business of developing genetic drugs for anti-tumor activities. It focuses on the development of AP-002 a new chemical entity small and novel molecule, that selectively targets bone resorption while also demonstrating anti-tumor activities. The company is headquartered in Canada. | Health Technology |
